Home » Newsletters » BioWorld

BioWorld

Nov. 19, 1991

View Archived Issues

CEPHALON TO STUDY RETINAL DISEASES

TSI GETS GRANT FOR WATANABE RABBITS

MATRIX GETS INDs FOR CANCER DRUGS

MICROPROBE RAISES $2.9 MILLION

GENZYME'S r-GCR GETS ORPHAN DESIGNATION

PROTEIN DEVICE TO REPAIR FRACTURES

SCHERING SUES STERLING OVER IL-4

EARLY SUCCESS WITH OVARIAN CANCER DRUG

AURICULIN HELPS PREVENT KIDNEY TOXICITY

NOVEN GRANTS DELIVERY SYSTEM RIGHTS

CENTOCOR TO CO-DEVELOP MAbs WITH CORVAS

STOCKS REBOUND, BUT MAY HAVE PEAKED

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 5, 2025.
Highridge sells bone healing business to Avista
BioWorld MedTech
In the midst of June’s peak wedding season, Highridge Medical LLC called it splitsville – selling its bone healing division to Avista Healthcare Partners. The...
Regenxbio’s Duchenne gene therapy data positive as shares falter
BioWorld
Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...
Pharma execs speak out: UK pricing rebates scare investors
BioWorld
The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...